New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
16:39 EDTTLM, HES, ESL, VSI, BG, ITW, HOLX, DGX, IR, TKR, RPMRelational Investors gives quarterly update on stakes
NEW STAKES: Rpm International (RPM). INCREASED STAKES: Hologic (HOLX), Esterline (ESL) and Timken (TKR). DECREASED STAKES: Illinois Tool Works (ITW), Hess (HES), Ingersoll-Rand (IR) and Bunge (BG). LIQUIDATED STAKES: Talisman (TLM), Quest Diagnostics (DGX) and Vitamin Shoppe (VSI).
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2015
18:31 EDTDGXQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for OPDIVO
Subscribe for More Information
13:02 EDTESLFirst Pacific reports 10.7% passive stake in Esterline
Subscribe for More Information
12:04 EDTBGUSDA cuts U.S. corn, soy acerage estimates
Subscribe for More Information
08:33 EDTHOLXAmerican Society for Bone & Mineral Research to hold annual meeting
Subscribe for More Information
October 8, 2015
14:31 EDTRPMRPM increases dividend 5.8% to 27.5c per share
RPM International announced at its annual meeting of stockholders that its board of directors declared a regular quarterly cash dividend of 27.5c per share, payable on October 30, to stockholders of record as of October 19. This payment represents a 5.8% increase over the 26c quarterly cash dividend paid at this time last year.
October 7, 2015
06:56 EDTRPMRPM lowers FY16 EPS view to $2.50 from $2.55, consensus $2.56
Subscribe for More Information
06:53 EDTRPMRPM reports Q1 EPS 74c, consensus 81c
Reports Q1 revenue $1.24B, consensus $1.27B. Q1 performance was impacted by the continuing strength of the U.S. dollar against most foreign currencies, coupled with rainy weather in North America. The company anticipates "a return to solid growth" in the consumer segment for the balance of the year. Additionally, in Q1 the combination of translational and transactional foreign exchange reduced EPS by 8c.
October 6, 2015
15:08 EDTRPMNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Monsanto (MON), consensus (2c)... Constellation Brands (STZ), consensus $1.32... Acuity Brands (AYI), consensus $1.62... Global Payments (GPN), consensus $1.43... RPM International (RPM), consensus 82c.
12:49 EDTDGXIllumina plummets after 2H15 revenue forecast trails estimates
Shares of Illumina (ILMN), which produces tools for genetic analysis, are sinking after the company forecast lower than expected revenue for the third and fourth quarters. Illumina also lowered its fiscal 2015 revenue growth forecast to 18% from 20%. WHAT'S NEW: Illumina yesterday announced preliminary Q3 revenue of approximately $550M, below analysts' consensus estimates of $568.6M. Additionally, the company forecast Q4 revenue of approximately $570M, well below analysts' estimates of $602.83M. Illumina also lowered its forecast for 2015 revenue growth to approximately 18% from its prior view of approximately 20%, including a 3% negative impact from foreign exchange, against analysts' consensus estimates of $2.25B. WHAT'S NOTABLE: Jay Flatley, Illumina's chief executive officer, noted that although the company saw strong demand for sequencing consumables and the HiSeq family of instruments in Q3, instrument sales in the desktop family underperformed company expectations. He said management was "disappointed with instrument sales in Europe and continued weakness in the Asia-Pacific region." Flatley said that the new markets the company is targeting are "enormous," and will support revenue growth for Illumina in 2016 and beyond. The company is expected to provide updated earnings per share guidance on October 20, when the company reports Q3 results. ANALYST REACTION: Sentiment on the Street was mixed at midday. Research firms Mizuho and BTIG downgraded Illumina to Neutral from Buy. In addition, UBS, Stifel, and Cowen all lowered their respective price targets on Illumina shares. Conversely, Piper and Wells Fargo said they would be buyers of Illumina on today's weakness. Another firm, Canaccord, said the Illumina news not all bad and maintained its Buy rating and $250 price target on Illumina shares. PRICE ACTION: In midday trading, Illumina fell $23.17, or about 14.2%, to $140.01 on more than six times its average daily trading volume. Including today's pull back, the shares have lost approximately 14% over the past 12 months. OTHERS TO WATCH: Other companies in the diagnostic business include Affymetrix (AFFX), down 4.1%, HTG Molecular Diagnostics (HTGM), down 4.2%, Quest Diagnostics (DGX), down 3.5%, Pacific Biosciences (PACB), down 2.4%, and Thermo Fisher Scientific (TMO), down 2.7%.
12:29 EDTDGXFDA clears Focus Diagnostics' Simplexa flu test to include new strains
Focus Diagnostics, the products business of Quest Diagnostics, announced that its Simplexa Flu A/B & RSV Direct Kit has received 510k clearance from the U.S. Food and Drug Administration for 46 additional influenza A and influenza B virus strains and 7 additional respiratory syncytial virus strains. The FDA granted 510k initial clearance to the Simplexa test kit for select virus strains in July 2012 and clearance of some additional strains in 2014. With the recent clearance, the Simplexa test can detect a total of 92 influenza and RSV virus strains, more than any other FDA-cleared molecular test kit. These include all four influenza strains the World Health Organization recommends be included in vaccines during the northern hemisphere's 2015-2016 influenza season: A/Switzerland/9715293/2013 H3N2-like virus; A/California/7/2009 H1N1-like virus, B/Phuket/3073/2013-like virus and B/Brisbane/60/2008-like virus. In addition, the 46 new influenza strains include 20 avian influenza A and two swine influenza virus strains. These may be increasingly important to detect, as avian and swine influenza viruses can carry over into human populations.
08:32 EDTTKRKaman to acquire Timken Alcor Aerospace Technologies
Subscribe for More Information
October 5, 2015
08:04 EDTBGBunge purchases Whole Harvest Foods, LLC
Bunge North America, the North American operating arm of Bunge, announced that it purchased Whole Harvest Foods, a refiner and packager of expeller pressed commercial cooking oil. Whole Harvest Foods products, which including frying oils, pan sprays and liquid butter alternatives are manufactured at its vegetable oil refinery and packaging facility in Warsaw, North Carolina, and its packaging plant in Las Vegas, Nevada. Financial terms were not disclosed.
October 2, 2015
15:43 EDTDGXQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
September 29, 2015
10:00 EDTBGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Apache (APA) upgraded to Overweight from Neutral at Simmons... Autoliv (ALV) upgraded to Neutral from Sell at Goldman... Bristol-Myers (BMY) upgraded to Buy from Neutral at UBS... Bunge (BG) upgraded to Outperform from Market Perform at BMO Capital... Cerner (CERN) upgraded to Outperform from Sector Perform at RBC Capital... Continental AG (CTTAY) upgraded to Conviction Buy from Buy at Goldman... Digital Realty (DLR) upgraded to Overweight from Sector Weight at KeyBanc... FTD Companies (FTD) upgraded to Buy from Neutral at Sidoti... Intermolecular (IMI) upgraded to Outperform from Market Perform at Northland... Johnson & Johnson (JNJ) upgraded to Buy from Hold at Deutsche Bank... LDR Holding (LDRH) upgraded to Outperform from Market Perform at Northland... Lincoln National (LNC) upgraded to Overweight from Neutral at Piper Jaffray... McDonald's (MCD) upgraded to Outperform from Neutral at Credit Suisse... Micron (MU) upgraded to Outperform from Market Perform at Wells Fargo... Nautilus (NLS) upgraded to Buy from Neutral at B. Riley... Nevsun Resources (NSU) upgraded to Outperform from Sector Perform at Scotia... Nexstar (NXST) upgraded to Buy from Hold at Jefferies... Omega Protein (OME) upgraded to Buy from Neutral at DA Davidson... Raytheon (RTN) upgraded to Buy from Neutral at UBS... Republic Airways (RJET) upgraded to Buy from Hold at Deutsche Bank... Swiss Re (SSREY) upgraded to Neutral from Underweight at JPMorgan... Thor Industries (THO) upgraded on positive trends, checks at BMO Capital... Verint (VRNT) upgraded to Outperform from Market Perform at William Blair.
06:42 EDTBGBunge upgraded to Outperform from Market Perform at BMO Capital
Subscribe for More Information
06:16 EDTBGBunge upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use